ScholarDeck

Cohort studyArchivos de cardiologia de Mexico · 2026

Outcomes of thoracic endovascular aortic repair. 10-years follow-up in LATAM population: experience from a tertiary care center in Mexico.

Jhonathan Uribe-González, Erick Trujillo-Virgen, Daniela Leocachín-Parra … Joel Estrada-Gallegos

CardiologyCohort study

TEVAR achieved high technical success in a single-center cohort study.

Outcomes of thoracic endovascular aortic repair. 10-years follow-up in LATAM population: experience from a tertiary care center in Mexico.

Jhonathan Uribe-González et al. · Archivos de cardiologia de Mexico · 2026

Background

Thoracic aortic pathologies comprise a broad group of conditions affecting one or more layers of the aorta, some of which are known to be life-threatening.

Purpose

To describe clinical and technical outcomes of patients who underwent thoracic endovascular aortic repair (TEVAR) in a single tertiary care center.

Methods

An observational, descriptive, retrospective cohort study.

n = 66 patients

95.4%

Results

most patients had the minimally invasive heart repair procedure work as intended

n = 66 patients

More results

The most frequent cardiovascular risk factors were hypertension and tobacco use.

Event-free survival was 81.8% (n = 54) during hospitalization, 81.5% (n = 54) at 30 days, 76.9% (n = 50) at 1 year, 75.4% (n = 43) at 5 years, and 63.6% (n = 21) at 10 years.

More results

Adverse events occurred in 27.2% (n = 18) of cases, most commonly vascular access complications (12.1%, n = 8), spinal cord ischemia (4.5%, n = 3), and reintervention (4.5%, n = 3).

“

Conclusion · 1 of 2

In this retrospective single-center experience, TEVAR demonstrated high technical success and acceptable mid- and long-term event-free survival.

Conclusion · 2 of 2

These findings support the feasibility and effectiveness of TEVAR in a tertiary-level care setting.

Post

Outcomes of thoracic endovascular aortic repair. 10-years follow-up in LATAM population: experience from a tertiary care center in Mexico.

TEVAR achieved high technical success in a single-center cohort study.

Related papers